Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

NCT00005991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]